Document Detail


Depression and diabetes: impact of antidepressant medications on glycaemic control.
MedLine Citation:
PMID:  24968546     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
INTRODUCTION: One of the consistent findings among various studies on diabetes has been the prevalence of depression with or without comorbid anxiety among patients of Diabetes Mellitus. Also, numerous other studies have pointed to the negative bearing of the same on blood sugar levels among patients. However there is a lack of data on the outcome of treatment with anti-depressants on the blood glucose level. Considering the ever increasing population of diabetics in our country and the significant causal relationship established by current literature, this study was undertaken.
AIMS AND OBJECTIVES: To study prevalence of depression and anxiety in patients of Type 2 Diabetes Mellitus with an increase in blood glucose levels. To study the socio-demographic profile and role of stressors in patients of Type 2 Diabetes Mellitus. To study the effects of management of depression and anxiety on blood glucose levels in patients of Type 2 Diabetes Mellitus.
MATERIAL AND METHODS: Sample Size: 100 Consecutive 100 patients diagnosed with Type 2 Diabetes Mellitus(DM) fulfilling the inclusion and exclusion criteria were included in the study. Ethics committee approval was taken for the study.The sociodemographic details of the patients were collected using a specially designed semi-structured proforma. Patients were evaluated for psychiatric disorders using DSM IV TR criteria for diagnosis and Montgomery Asberg Depression Rating Scale (MADRS) and Hamilton Anxiety Rating Scale(HAM-A) were used thereafter to assess the severity of depression and anxiety, respectively. Patients detected with depression and / or anxiety were started on T. Escitalopram (10 mg); keeping the management of DM unchanged. Patients were reviewed after 6 weeks from date of initial assessment and blood glucose levels were repeated. Data thus collected was analysed using SPSS Software.
RESULTS: The prevalence of depression with/without anxiety in the study was 39%. Among depressed patients stressors were found in 84% of patients with social and interpersonal stressors as the more prevalent types. The socio-economic profile showed a female preponderance, lower to middle socioeconomic and educational status and majority were married. 47% of the patients started on T. Escitalopram showed lower fasting and post-lunch blood sugar values on follow up, which was clinically and statistically significant.
Authors:
H S Dhavale; Vijay Panikkar; Bindoo S Jadhav; Mangesh Ghulghule; Adita D Agari
Related Documents :
23592556 - Mindfulness and emotion regulation in depression and anxiety: common and distinct mecha...
24916246 - Starting out - my experience of depression helped me support my patient through it.
22930656 - The more it is needed, the less it is wanted: attitudes toward face-to-face interventio...
24424706 - A meta-analysis of inositol for depression and anxiety disorders.
21261656 - Prospective validation of 'allergy-control-score(tm) ': a novel symptom-medication scor...
2553636 - Thymomodulin increases the depressed production of superoxide anion by alveolar macroph...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of the Association of Physicians of India     Volume:  61     ISSN:  0004-5772     ISO Abbreviation:  J Assoc Physicians India     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2014-06-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7505585     Medline TA:  J Assoc Physicians India     Country:  India    
Other Details:
Languages:  eng     Pagination:  896-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants.
Next Document:  Dabigatran etexilate in atrial fibrillation.